Open | $0.248 |
Close | $0.248 |
Volume / Avg. | 177.949K / 2.439M |
Day Range | 0.240 - 0.270 |
52 Wk Range | 0.180 - 3.290 |
Market Cap | $3.096M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | % |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Yield10 Bioscience (NASDAQ: YTEN) through any online brokerage.
Other companies in Yield10 Bioscience’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Geovax Labs (NASDAQ:GOVX) and TransCode Therapeutics (NASDAQ:RNAZ).
The latest price target for Yield10 Bioscience (NASDAQ: YTEN) was reported by Lake Street on Thursday, February 8, 2024. The analyst firm set a price target for 0.50 expecting YTEN to rise to within 12 months (a possible 93.50% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Yield10 Bioscience (NASDAQ: YTEN) is $0.2584 last updated March 18, 2024 at 4:28 PM EDT.
There are no upcoming dividends for Yield10 Bioscience.
Yield10 Bioscience’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Yield10 Bioscience.
Yield10 Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.